Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation

Journal Title: Jornal de Pediatria - Year 2019, Vol 95, Issue 3

Abstract

Objective To describe the results obtained in a neonatal screening program after its implementation and to assess the clinical and molecular profiles of confirmed and suspicious congenital adrenal hyperplasia cases. Methods A cross-sectional study was conducted. Newborns with suspected disease due to high 17-hydroxyprogesterone levels and adjusted for birth weight were selected. Classical congenital adrenal hyperplasia (salt-wasting and simple virilizing forms) was diagnosed by an increase in 17-hydroxyprogesterone levels as confirmed in the retest, clinical evaluation, and genotype determined by SNaPshot and multiplex ligation-dependent probe amplification. Results After 24 months, 15 classic congenital adrenal hyperplasia cases were diagnosed in a total of 217,965 newborns, with an estimated incidence of 1:14,531. From 132 patients, seven non-classical and 14 heterozygous patients were screened for CYP21A2 mutations, and 96 patients presented false positives with wild type CYP21A2. On retest, increased 17-hydroxyprogesterone levels were found in classical congenital adrenal hyperplasia patients and showed significant correlation with genotype-related classical genital adrenal hyperplasia. The most frequent mutations were IVS2-13A/C>G followed by gene deletion or rearrangement events in the classical form. In non-classical and heterozygous diseases, p.Val282Leu was the most common mutation. Conclusions The results underscore the effectiveness of congenital adrenal hyperplasia neonatal screening in the public health system and indicate that the adopted strategy was appropriate. The second sample collection along with genotyping of suspected cases helped to properly diagnose both severe and milder cases and delineate them from false positive patients.

Authors and Affiliations

Cristiane Kopacek

Keywords

Related Articles

Fecal calprotectin levels in preterm infants with and without feeding intolerance

Objectives To assess the level of fecal calprotectin in preterm neonates with feeding intolerance, as well as to evaluate it as a marker of feeding intolerance and to determine a cut-off level of fecal calprotectin in fe...

Another reason to favor exclusive breastfeeding: microbiome resilience

Knowledge of the human microbiome has rapidly accelerated thanks to the Human Microbiome Project and the increasing availability of culture independent high-throughput sequencing technology. With these new tools, we have...

Translation and validation of the Transition Readiness Assessment Questionnaire (TRAQ)

Objective To translate and validate the Brazilian Portuguese version of the Transition Readiness Assessment Questionnaire in a population of adolescents and young adults with chronic rheumatologic disorders. This questio...

Use of macrolides in lung diseases: recent literature controversies

Objective To review the mechanisms of action of macrolides in pediatric respiratory diseases and their clinical indications. Sources Review in the PubMed database, comprising the following terms in English: “macrolide a...

Influence of socioeconomic and psychological factors in glycemic control in young children with type 1 diabetes mellitus

Objective To evaluate the influence of socioeconomic and psychological factors on glycemic control in young children with type 1 diabetes mellitus. Methods This was a cross-sectional study assessing prepubertal children...

Download PDF file
  • EP ID EP575272
  • DOI 10.1016/j.jped.2018.03.003
  • Views 30
  • Downloads 0

How To Cite

Cristiane Kopacek (2019). Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation. Jornal de Pediatria, 95(3), 282-290. https://europub.co.uk/articles/-A-575272